DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $477,000 | -46.0% | 23,671 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $883,000 | +55.2% | 23,671 | +6.3% | 0.00% | +100.0% |
Q1 2021 | $569,000 | +16.8% | 22,264 | +0.7% | 0.00% | 0.0% |
Q4 2020 | $487,000 | +22.4% | 22,114 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $398,000 | -27.2% | 22,114 | +2.7% | 0.00% | 0.0% |
Q2 2020 | $547,000 | +38.5% | 21,524 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $395,000 | -16.7% | 21,524 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $474,000 | +54.9% | 21,524 | +0.9% | 0.00% | 0.0% |
Q3 2019 | $306,000 | -8.9% | 21,334 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $336,000 | +25.8% | 21,334 | +17.0% | 0.00% | 0.0% |
Q1 2019 | $267,000 | +36.9% | 18,234 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $195,000 | -15.9% | 18,234 | +19.9% | 0.00% | 0.0% |
Q3 2018 | $232,000 | +30.3% | 15,210 | +4.7% | 0.00% | – |
Q2 2018 | $178,000 | – | 14,530 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 4,080,237 | $74,954,000 | 12.68% |
Aquilo Capital Management, LLC | 1,237,379 | $22,731,000 | 8.86% |
EcoR1 Capital, LLC | 3,346,301 | $61,472,000 | 6.42% |
RTW INVESTMENTS, LP | 6,963,135 | $127,913,000 | 5.51% |
BRIDGER MANAGEMENT, LLC | 1,679,344 | $30,850,000 | 3.57% |
Parkman Healthcare Partners LLC | 300,805 | $5,526,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 256,500 | $4,712,000 | 2.28% |
Integral Health Asset Management, LLC | 185,000 | $3,398,000 | 1.50% |
DAFNA Capital Management LLC | 147,714 | $2,714,000 | 1.13% |
EAM Global Investors LLC | 88,465 | $1,625,000 | 0.95% |